Filing Details
- Accession Number:
- 0001209191-22-029923
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-18 11:04:05
- Reporting Period:
- 2022-05-17
- Accepted Time:
- 2022-05-18 11:04:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1698751 | T. Michael Andriole | 2505 Meridian Parkway, Suite 100 Durham NC 27713 | Chief Business Officer And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-17 | 15,000 | $1.71 | 212,724 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.705 to $1.71, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- Includes: i) 13,273 shares acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") on September 10, 2020; ii) 17,361 shares acquired under the Issuer's ESPP on March 10, 2021; and iii) 17,361 shares acquired under the Issuer's ESPP on March 10, 2022.